Raritan Pharmaceuticals, Inc.
FDA-inspected organization
Raritan Pharmaceuticals, Inc. has been audited by the FDA 10 times between 2003 and 2018 across all 1 sites.
Documents
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2018
Out of stock
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2016
Out of stock
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2016
Out of stock
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2012
Out of stock
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2012
Out of stock
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2007
Out of stock
FDA 483 Raritan Pharmaceuticals, Inc., East Brunswick | 2005
Out of stock
FDA Investigators (14)
- Guerlain Ulysse, FDA Investigator
- James R. Birkenstamm, FDA Investigator
- Esteban Beltran, FDA Investigator
- Barbara J. Wilimczyk-Macri, FDA Investigator
- Gobiga Vanniyasingam, FDA Investigator
- Frederick Razzaghi, FDA Investigator
- Nicholas A. Violand, FDA Investigator
- Maria Estrella, FDA Investigator
- Anna M. Brannen, FDA Investigator
- Meredith L. Sheridan, FDA Investigator
- Addam S. Reynolds, FDA Investigator
- Daniel J. Grabicki, FDA Investigator
- Kristy A. Zielny, FDA Investigator
- Ernest Bizjak, FDA Investigator